Important effect of food on the bioavailability of oral testosterone undecanoate

被引:62
|
作者
Bagchus, WM
Hust, R
Maris, F
Schnabel, PG
Houwing, NS
机构
[1] Organon, Dept Clin Pharmacol, NL-5340 BH Oss, Netherlands
[2] Organon, Dept Drug Metab & Kinet, NL-5340 BH Oss, Netherlands
[3] Focus Clin Drug Dev GMBH, Neuss, Germany
来源
PHARMACOTHERAPY | 2003年 / 23卷 / 03期
关键词
D O I
10.1592/phco.23.3.319.32104
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To assess the effects of food on the bioavailability of testosterone undecanoate, testosterone, and 5alpha-dihydrotestosterone (DHT) after administration of a new oral testosterone undecanoate formulation, Andriol Testocaps. Design. Randomized, open-label, crossover study with a 1-week washout period. Setting. Clinical pharmacology unit. Subjects. Sixteen healthy postmenopausal women. Intervention. Single oral doses of testosterone undecanoate 80 mg were administered either during a fasting period or after consumption of a standardized continental breakfast. Measurements and Main Results. Serum concentrations of testosterone undecanoate were assayed by liquid chromatography with mass spectrometry detection; testosterone and DHT were assayed by gas chromatography with mass spectrometry detection. Serum concentrations of testosterone, testosterone undecanoate, and DHT were low to negligible when testosterone undecanoate was administered to subjects in a fasting state; these values were significantly higher when the test drug was coadministered with food. For testosterone, the maximum serum concentration and area under the plasma concentration-time curve were 0.67 ng/ml and 5.37 ng.hr/ml, respectively, in the fasting state, versus 10.7 ng/ml and 56.4 ng.hr/ml, respectively, in the fed state. The same parameters were also significantly higher for testosterone undecanoate and DHT in the fed versus fasting subjects. Conclusion. Food increases the bioavailability of testosterone undecanoate, testosterone, and DHT. For proper absorption, Andriol Testocaps must be taken with meals.
引用
收藏
页码:319 / 325
页数:7
相关论文
共 50 条
  • [21] Effect of food on the oral bioavailability of ezetimibe.
    Courtney, RD
    Kosoglou, T
    Statkevich, P
    Boutros, T
    Maxwell, SE
    Batra, VK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P80 - P80
  • [22] Testosterone undecanoate and testosterone cyclodextrin
    Wang, C
    Swerdloff, RS
    PHARMACOLOGY, BIOLOGY, AND CLINICAL APPLICATIONS OF ANDROGENS: CURRENT STATUS AND FUTURE PROSPECTS, 1996, : 487 - 491
  • [23] Effect of food on the relative bioavailability of oral ganciclovir
    Lavelle, J
    Follansbee, S
    Trapnell, CB
    Buhles, WC
    Griffy, KG
    Jung, D
    Dorr, A
    Conner, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (03): : 238 - 241
  • [24] EFFECTS OF A NEW ORAL TESTOSTERONE UNDECANOATE (TLANDO) THERAPY ON LIVER
    Patel, Mahesh
    Chidambaram, Nachiappan
    Papangkorn, Kongnara
    Baker, Jonathan
    Kim, Kilyoung
    DelConte, Anthony
    Goldstein, Irwin
    Miner, Martin
    Vignozzi, Linda
    Kaminetsky, Jed
    Khera, Mohit
    JOURNAL OF UROLOGY, 2020, 203 : E545 - E545
  • [25] INCREASING CIRCULATING ANDROGENS WITH ORAL TESTOSTERONE UNDECANOATE IN EUGONADAL MEN
    DAVIDSON, DW
    OCARROLL, R
    BANCROFT, J
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 26 (06): : 713 - 715
  • [26] LONG-TERM SAFETY OF THE ORAL ANDROGEN TESTOSTERONE UNDECANOATE
    GOOREN, LJG
    INTERNATIONAL JOURNAL OF ANDROLOGY, 1986, 9 (01): : 21 - 26
  • [27] TREATMENT OF ANORCHIA WITH ORAL TESTOSTERONE UNDECANOATE - PHARMACODYNAMICS AND CLINICAL EFFECTIVENESS
    WEIL, J
    BIDLINGMAIER, F
    BUTENANDT, O
    SIPPELL, WG
    BAUMGARTNER, W
    KNORR, D
    ACTA ENDOCRINOLOGICA, 1980, 95 (02): : 244 - 250
  • [28] Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism
    Miner, Martin
    Wang, Christina
    Kaminetsky, Jed
    Khera, Mohit
    Goldstein, Irwin
    Carson, Culley
    Chidambaram, Nachiappan
    King, Shelby
    Dobs, Adrian
    ANDROLOGY, 2024,
  • [29] PLASMA ANDROGENS AFTER A SINGLE ORAL DOSE OF TESTOSTERONE UNDECANOATE
    GEERE, G
    JONES, J
    ATHERDEN, SM
    GRANT, DB
    ARCHIVES OF DISEASE IN CHILDHOOD, 1980, 55 (03) : 218 - 220
  • [30] WEIGHT-GAIN UNDER ORAL TESTOSTERONE UNDECANOATE IN AIDS
    JEANTILS, V
    NGUYEN, G
    BACLE, F
    THOMAS, M
    KRIVITZKY, A
    THERAPIE, 1993, 48 (01): : 71 - 72